Clinical trials
Neurodegenerative Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 10 |
| Active, not recruiting | 9 |
| Terminated | 8 |
| Unknown status | 2 |
| No longer available | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GenSight Biologics | 4 |
| University of Exeter | 4 |
| Eli Lilly and Company | 3 |
| MODAG GmbH | 3 |
| TauRx Therapeutics Ltd | 3 |
| AstraZeneca | 2 |
| Bial R&D Investments, S.A. | 2 |
| Imperial College London | 2 |
| Novartis | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodegenerative Diseases | 50 |
| Alzheimer Disease | 20 |
| Nervous System Diseases | 19 |
| Dementia | 16 |
| Brain Diseases | 14 |
| Central Nervous System Diseases | 14 |
| Parkinson Disease | 13 |
| Tauopathies | 10 |
| Genetic Diseases, Inborn | 9 |
| Mental Disorders | 9 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.